<b>Background:</b> To assess the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) used as an adjunct to insulin therapy in adults with type 1 diabetes. Here, INS is linked to type 1 diabetes mellitus.